Skip to main content
Top
Published in: European Journal of Nutrition 5/2018

01-08-2018 | Original Contribution

SEPP1 polymorphisms modulate serum glucose and lipid response to Brazil nut supplementation

Authors: Janaina L. S. Donadio, Marcelo M. Rogero, Elvira M. Guerra-Shinohara, Charles Desmarchelier, Patrick Borel, Silvia M. F. Cozzolino

Published in: European Journal of Nutrition | Issue 5/2018

Login to get access

Abstract

Purpose

The consumption of Brazil nuts has been associated with benefits to lipid metabolism and reductions in total cholesterol and LDL concentrations. They are the richest natural source of selenium which has essential functions in human physiology. Genetic polymorphisms in Selenoprotein P could impair lipid and glucose metabolisms. The aim of this work was to verify the influence of polymorphisms in genes for selenoproteins on blood lipid levels after dietary supplementation with Brazil nuts in healthy adults.

Methods

The study included 130 healthy volunteers selected at the University of São Paulo, Brazil. They were supplemented with one nut a day for 8 weeks, followed by 8 weeks without intervention. The following analyses were performed: anthropometric measurements, serum fasting glucose, lipid profile, C-reactive protein and plasma MDA levels. The volunteers were genotyped for SNPs rs1050450, rs3811699, rs1800699, rs713041, rs3877899, rs7579, rs34713741, and rs5845 in genes for selenoproteins.

Results

The concentrations of total cholesterol and fasting glucose levels decreased after 8 weeks of supplementation (p < 0.05). Glucose levels were modulated by rs3877899 in SEPP1, with significantly lower levels observed for individuals with the GA + AA genotype (p = 0.025). In addition, rs7579 was associated with cholesterol concentrations, which were significantly lower for individuals with the GG genotype (p = 0.053).

Conclusions

Supplementation with one Brazil nut a day for 8 weeks reduced total cholesterol and glucose levels. Furthermore, our results suggest that rs3877899 might be associated with glucose concentrations and rs7579 with cholesterol concentrations. Therefore, the effect of genetic variations should be considered in future nutritional interventions evaluating the response to Brazil nut supplementation.
Literature
4.
go back to reference Mukuddem-Petersen J, Oosthuizen W, Jerling JC (2005) A systematic review of the effects of nuts on blood lipid profiles in humans. J Nutr 135:2082–2089CrossRefPubMed Mukuddem-Petersen J, Oosthuizen W, Jerling JC (2005) A systematic review of the effects of nuts on blood lipid profiles in humans. J Nutr 135:2082–2089CrossRefPubMed
5.
go back to reference Welna M, Klimpel M, Zyrnicki W (2008) Investigation of major and trace elements and their distributions between lipid and non-lipid fractions in Brazil nuts by inductively coupled plasma atomic optical spectrometry. Food Chem 111:1012–1015. doi:10.1016/j.foodchem.2008.04.067 CrossRef Welna M, Klimpel M, Zyrnicki W (2008) Investigation of major and trace elements and their distributions between lipid and non-lipid fractions in Brazil nuts by inductively coupled plasma atomic optical spectrometry. Food Chem 111:1012–1015. doi:10.​1016/​j.​foodchem.​2008.​04.​067 CrossRef
10.
go back to reference Maranhão PA, Kraemer-Aguiar LG, de Oliveira CL et al (2011) Brazil nuts intake improves lipid profile, oxidative stress and microvascular function in obese adolescents: a randomized controlled trial. Nutr Metab (Lond) 8:32. doi:10.1186/1743-7075-8-32 CrossRef Maranhão PA, Kraemer-Aguiar LG, de Oliveira CL et al (2011) Brazil nuts intake improves lipid profile, oxidative stress and microvascular function in obese adolescents: a randomized controlled trial. Nutr Metab (Lond) 8:32. doi:10.​1186/​1743-7075-8-32 CrossRef
12.
go back to reference Thomson CD, Chisholm A, Mclachlan SK, Campbell JM (2008) Brazil nuts: an effective way to improve selenium status. Am J Clin Nutr 87:379–384CrossRefPubMed Thomson CD, Chisholm A, Mclachlan SK, Campbell JM (2008) Brazil nuts: an effective way to improve selenium status. Am J Clin Nutr 87:379–384CrossRefPubMed
16.
go back to reference Yang SJ, Hwang SY, Choi HY et al (2011) Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis. J Clin Endocrinol Metab 96:1325–1329. doi:10.1210/jc.2011-0620 CrossRef Yang SJ, Hwang SY, Choi HY et al (2011) Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis. J Clin Endocrinol Metab 96:1325–1329. doi:10.​1210/​jc.​2011-0620 CrossRef
20.
go back to reference Méplan C, Crosley LK, Nicol F et al (2007) Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study). FASEB J 21:3063–3074. doi:10.1096/fj.07-8166com CrossRefPubMed Méplan C, Crosley LK, Nicol F et al (2007) Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study). FASEB J 21:3063–3074. doi:10.​1096/​fj.​07-8166com CrossRefPubMed
21.
go back to reference AOAC Association of Official Analytical Chemists (1990) Official methods of analysis, 15th ed. Washington AOAC Association of Official Analytical Chemists (1990) Official methods of analysis, 15th ed. Washington
27.
go back to reference Rayman MP, Stranges S, Griffin BA et al (2011) Effect of supplementation with high-selenium yeast on plasma lipids. Ann Intern Med 154:656–665CrossRefPubMed Rayman MP, Stranges S, Griffin BA et al (2011) Effect of supplementation with high-selenium yeast on plasma lipids. Ann Intern Med 154:656–665CrossRefPubMed
29.
30.
go back to reference Klopotek A, Hirche F, Eder K (2006) PPAR gamma ligand troglitazone lowers cholesterol synthesis in HepG2 and Caco-2 cells via a reduced concentration of nuclear SREBP-2. Exp Biol Med 231:1365–1372CrossRef Klopotek A, Hirche F, Eder K (2006) PPAR gamma ligand troglitazone lowers cholesterol synthesis in HepG2 and Caco-2 cells via a reduced concentration of nuclear SREBP-2. Exp Biol Med 231:1365–1372CrossRef
Metadata
Title
SEPP1 polymorphisms modulate serum glucose and lipid response to Brazil nut supplementation
Authors
Janaina L. S. Donadio
Marcelo M. Rogero
Elvira M. Guerra-Shinohara
Charles Desmarchelier
Patrick Borel
Silvia M. F. Cozzolino
Publication date
01-08-2018
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 5/2018
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-017-1470-7

Other articles of this Issue 5/2018

European Journal of Nutrition 5/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.